These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34823433)

  • 1. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology.
    Kumar R; Aadil KR; Mondal K; Mishra YK; Oupicky D; Ramakrishna S; Kaushik A
    Crit Rev Biotechnol; 2022 Dec; 42(8):1180-1212. PubMed ID: 34823433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner.
    Nehra M; Uthappa UT; Kumar V; Kumar R; Dixit C; Dilbaghi N; Mishra YK; Kumar S; Kaushik A
    J Control Release; 2021 Oct; 338():224-243. PubMed ID: 34418523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.
    Wang Z; Gonzalez KM; Cordova LE; Lu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1907. PubMed ID: 37248794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
    Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
    Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction.
    Giménez S; Millan A; Mora-Morell A; Ayuso N; Gastaldo-Jordán I; Pardo M
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective.
    Ashique S; Afzal O; Yasmin S; Hussain A; Altamimi MA; Webster TJ; Altamimi ASA
    Int J Pharm; 2023 Feb; 633():122614. PubMed ID: 36646255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
    Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
    J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management.
    Mujawar MA; Gohel H; Bhardwaj SK; Srinivasan S; Hickman N; Kaushik A
    Mater Today Chem; 2020 Sep; 17():100306. PubMed ID: 32835155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.
    Ali A; Sheikh IA; Mirza Z; Gan SH; Kamal MA; Abuzenadah AM; Damanhouri GA; Ashraf GM
    Curr Drug Metab; 2015; 16(5):376-88. PubMed ID: 25495738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.
    Kumar S; Singh P; Sharma S; Pottoo FH; Ali J; Baboota S
    Comb Chem High Throughput Screen; 2021; 24(10):1544-1556. PubMed ID: 33334281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases.
    Di Martino P; Censi R; Gigliobianco MR; Zerrillo L; Magnoni F; Agas D; Quaglia W; Lupidi G
    Curr Pharm Des; 2017; 23(13):1897-1908. PubMed ID: 28025942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System.
    Shukla MK; Dubey A; Pandey S; Singh SK; Gupta G; Prasher P; Chellappan DK; Oliver BG; Kumar D; Dua K
    Curr Pharm Des; 2022; 28(39):3202-3211. PubMed ID: 35422206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform.
    Pinto M; Silva V; Barreiro S; Silva R; Remião F; Borges F; Fernandes C
    Ageing Res Rev; 2022 Aug; 79():101658. PubMed ID: 35660114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.